Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 6/20 | 0.46 |
| ▸ | NPC1 | O15118 | 5/20 | 0.44 |
| ▸ | RAB9A | P51151 | 4/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | GUSB | P08236 | 1/20 | 0.36 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.35 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11987295 | 0.90 | ATR (0.46) | ATRNPC1RAB9AHTTHPGD | |
| SCHEMBL11987284 | 0.83 | ATR (0.40) | ATRNPC1RAB9AHTTHPGD | |
| SCHEMBL11987281 | 0.83 | NPC1 (0.43) | ATRNPC1RAB9AHTTHPGD | |
| SCHEMBL11987282 | 0.80 | ATR (0.47) | ATRNPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL11987280 | 0.78 | NPC1 (0.53) | ATRNPC1RAB9AHPGDSMN1; SMN2 | |
| SCHEMBL11987263 | 0.78 | NPC1 (0.47) | ATRNPC1RAB9AHTTHPGD | |
| SCHEMBL11987291 | 0.78 | NPC1 (0.50) | ATRNPC1RAB9AHTTHPGD | |
| SCHEMBL11987287 | 0.78 | NPC1 (0.50) | ATRNPC1RAB9AHTTHPGD | |
| SCHEMBL11987293 | 0.75 | ATR (0.41) | ATRNPC1RAB9AHTTHPGD | |
| SCHEMBL11987294 | 0.75 | NPC1 (0.43) | ATRNPC1RAB9AHTTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8247087-B2 | Compound having oxadiazole ring structure bonded with aromatic heterocyclic ring and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-08-21 | — | — | US | disclosed |
| US-8247087-B2 | Compound having oxadiazole ring structure bonded with aromatic heterocyclic ring and organic electroluminescent device | HODOGAYA CHEMICAL CO., LTD. (JP) | 2012-08-21 | — | — | US | disclosed |
| US-20090230849-A1 | COMPOUND HAVING OXADIAZOLE RING STRUCTURE BONDED WITH AROMATIC HETEROCYCLIC RING AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2009-09-17 | — | — | US | disclosed |
| US-20090230849-A1 | COMPOUND HAVING OXADIAZOLE RING STRUCTURE BONDED WITH AROMATIC HETEROCYCLIC RING AND ORGANIC ELECTROLUMINESCENT DEVICE | HODOGAYA CHEMICAL CO., LTD. (JP) | 2009-09-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090230849-A1 | COMPOUND HAVING OXADIAZOLE RING STRUCTURE BONDED WITH AROMATIC HETEROCYCLIC RING AND ORGANIC ELECTROLUMINESCENT DEVICE | OXA1L, ORC3, OCIAD1 | ATR 577/4885NPC1 3174/4885RAB9A 4215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.